CN103965303A - Marine bacillus licheniformis protein and application thereof to cardiovascular field - Google Patents
Marine bacillus licheniformis protein and application thereof to cardiovascular field Download PDFInfo
- Publication number
- CN103965303A CN103965303A CN201310034684.2A CN201310034684A CN103965303A CN 103965303 A CN103965303 A CN 103965303A CN 201310034684 A CN201310034684 A CN 201310034684A CN 103965303 A CN103965303 A CN 103965303A
- Authority
- CN
- China
- Prior art keywords
- bacillus licheniformis
- dnn6
- dialysis
- protein
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A marine bacillus licheniformis protein. A preparation method comprises the following steps: inoculating a kelp endophytic bacillus licheniformis DNN6 strain to a liquid medium, wherein the liquid medium formula comprises 40-50g / L sucrose and 8-10g / L peptone, and has pH value adjusted to 9; bottling 150-250mL of the liquid medium into each bottle, and conducting shaking culture at temperature of 30-35 DEG C, rotating speed of 150-250 rpm for 4-5 days; centrifuging the fermentation liquid at 8000 r / min to remove thalli, then adding ammonium sulfate, wherein the saturation concentration of ammonium sulfate is 95%, and standing overnight at 4 DEG C; and filtering, dissolving the precipitate with distilled water, then conducting dialysis by using a dialysis bag with cut-off molecular weight of 3600 Dalton for 4 days, and conducting freeze-drying on the products in the dialysis bag, so as to obtain the marine endophytic bacillus licheniformis protein. The invention also provides the application of the protein to the cardiovascular field. The process is simple and low in cost.
Description
Technical field
The present invention relates to field of medicaments, particularly raw Bacillus licheniformis DNN6(in a main laminaria
bacillus licheniformisdNN6) strain protein and the application aspect cardiovascular.
Background technology
Sea-tangle (
laminaria Japonicaaresch) be a kind of raw brown alga plant in large-scale sea growing in low temperature seawater.It grows in lower marine of water temperature.Sea-tangle is mainly self-sow, also propagates artificially, mainly with dry products, is on sale throughout in city, and quality take that look brown, body is short, the thin and plump person of matter is as good.Sea-tangle has the good reputation of " longevity greens/mustard green ", " vegetables at sea " " containing iodine champion ".
Sea-tangle is as a kind of important oceanic resources, and it eats with pharmaceutical use and is early in the public eye.That the effective constituent of extracting from sea-tangle has is hypoglycemic, reducing blood-fat, antitumor, anti-HIV and strengthen immunologic function, to treatment cardiovascular and cerebrovascular diseases and in, early stage chronic kidney hypofunction etc. all has certain effect.In sea-tangle, also contain some attached microorganisms altogether, but these microorganisms and meta-bolites thereof are not only also fully utilized so far.
Summary of the invention
The object of this invention is to provide raw Bacillus licheniformis DNN6(in a kind of sea-tangle simple to operate, with low cost
bacillus licheniformisdNN6) strain protein and the application aspect cardiovascular thereof, to make full use of the common attached microorganism of sea-tangle, overcome the deficiencies in the prior art.
A kind of ocean of the present invention Bacillus licheniformis albumen, as follows preparation:
A. get raw Bacillus licheniformis DNN6(Bacillus licheniformis DNN6 in sea-tangle), this bacterial strain has been preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), preserving number: CGMCC No:7077 on December 31st, 2012;
B. Bacillus licheniformis DNN6 is inoculated in liquid nutrient medium, the formula of this liquid nutrient medium is: sucrose 40-50 g/L and peptone 8-10 g/L, and pH is deployed into 9;
C. b step finishes rear packing, every bottled 100-200 mL liquid nutrient medium, and temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days;
D. by the fermented liquid of c step centrifugal treating under the condition of 8000 r/min, remove thalline, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then are 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen.
The application of a kind of ocean of the present invention Bacillus licheniformis albumen aspect cardiovascular.
Ocean of the present invention Bacillus licheniformis protein preparation method technique is simple, with low cost, the albumen extracting the fermented liquid of raw lichem bacillus strain in sea-tangle has hypotensive activity, the development and the exploitation that can be applicable to Altace Ramipril, have industrial value.
The ocean lichem bacillus strain of applying in the present invention has been preserved in the China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) that is positioned at No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, preserving number: CGMCC No:7077 on December 31st, 2012.
embodiment
The embodiment of the present invention is carried out successively as follows:
A. strain Bacillus licheniformis DNN6 is inoculated in to sucrose 40-50 g/L and peptone 8-10 g/L, in the liquid nutrient medium that pH is 9, every bottled 100-200 mL liquid nutrient medium, temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days.This lichem bacillus strain has been preserved in the China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC) that is positioned at No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, preserving number: CGMCC No:7077 on December 31st, 2012.
B. by the centrifugal removal thalline of fermented liquid 8000 r/min, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then be 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen, SDS-PAGE electrophoresis result shows that this throw out is protein.
Get freeze-drying sample and with PBS solution, be dissolved into the solution of 1 mg/mL, use respectively the dosage of 180 mg/kg and 18 mg/kg, jugular vein administration SD rat (The 2nd Army Medical College Experimental Animal Center provides), two dosage all can make systolic pressure decline 3.17 ± 0.1 KPa; Isolated heart pours into the shrinkage amplitude that 18 mg/kg can reduce SD isolated rat heart.
C. the impact on rat blood pressure
Laboratory animal: male SD rat is purchased from The 2nd Army Medical College Experimental Animal Center.Experimental session, keeps Animal House room temperature 22 ℃ of left and right, relative humidity 70% left and right, early 8 extremely late 8 automatic illuminatings.Animal ad lib, freely drinks water.
The preparation of ductus arteriosus: PE10(internal diameter 0.3 cm, external diameter 0.5 cm) and PE50(internal diameter 0.58 mm, external diameter 0.96 mm) two kinds of specification conduits are prepared ductus arteriosus, PE10 pipe is docked by thin wire with PE50 pipe, after heating, press the protuberance that joint forms, cooling rear extraction iron wire, can apply after inspection joint is firm, unobstructed.
20% urethanum (urethane), 5 mL/kg intraperitoneal anesthesia rats, lain on the back and be fixed on animal constant temperature autopsy table, a separated side femoral artery, distal end ligation, proximal part inserts the arterial cannulation of filling with 1% heparin-saline, the opposite side connecting tee pipe of intubate is by by PowerLab MLT1199 invasive blood pressure measuring system, dynamically recording arteriotony.After blood pressure stabilization, by jugular vein intubate, to DNN6 strain protein (180 mg/kg and 18 mg/kg), and recording blood pressure changes.Experimental result shows that two dosage all can make systolic pressure decline 3.17 ± 0.1 KPa, have the potentiality of exploitation depressor.
D. the foundation of Isolated Rat heart model: by SD for rat after urethane (1.2 gkg-1) and heparin (400 IUkg-1) mixed solution intraperitoneal anesthesia, opening rapidly chest cores, by classical Langendorff method, through aorta ascendens, drive in the wrong direction and insert intrusion pipe, make it be placed in aortic valve top, in order to coronary perfusion.Adopt KH liquid to carry out balance perfusion, when front 30 min of perfusion and perfusion, fill with mixed gas (95% O2+5% CO2), make the KH liquid of balance perfusion fully reach oxygen saturation, pH value maintains 7.35 ~ 7.45, keeping filling temperature is 37.0 ℃ ~ 37.5 ℃, and injection pressure is 60 mmHg.Two suspension electrocardiographic recording electrodes are positioned over to pulmonary conus respectively and apex is guided out electrocardiogram(ECG, and the cardiac function index such as recorded heart rate.Experimental result shows 4 min after the K-H liquid perfusion heart of the albumen (18 mg/kg) with containing bacterial strain DNN6, and heart contraction amplitude reduces by 23%.With K-H liquid, recover after perfusion, heart contraction amplitude and rest tension recover gradually again.The hypotensive activity of bacterial strain DNN6 albumen may be relevant with reduction heart function.
Claims (2)
1. an ocean Bacillus licheniformis albumen, is characterized in that: preparation as follows:
A. get raw Bacillus licheniformis DNN6(in sea-tangle
bacillus licheniformisdNN6), this bacterial strain was preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (CGMCC), preserving number: CGMCC No:7077 on January 10th, 2013;
B. Bacillus licheniformis DNN6 is inoculated in liquid nutrient medium, the formula of this liquid nutrient medium is: sucrose 40-50 g/L and peptone 8-10 g/L, and pH is deployed into 9;
C. b step finishes rear packing, every bottled 100-200 mL liquid nutrient medium, and temperature 30-35 ℃, rotating speed is 150-200 rpm, shaking table is cultivated 4-5 days;
D. by the fermented liquid of c step centrifugal treating under the condition of 8000 r/min, remove thalline, then add ammonium sulfate, the saturated final concentration of ammonium sulfate is 95%, 4 ℃ of standing over night, filter and will precipitate with after distilled water dissolving, then are 3600 daltonian dialysis tubings dialysis 4 days with molecular weight cut-off, get thing lyophilize in dialysis tubing, obtain ocean Bacillus licheniformis albumen.
2. the application of ocean according to claim 1 Bacillus licheniformis albumen aspect cardiovascular.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310034684.2A CN103965303A (en) | 2013-01-30 | 2013-01-30 | Marine bacillus licheniformis protein and application thereof to cardiovascular field |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310034684.2A CN103965303A (en) | 2013-01-30 | 2013-01-30 | Marine bacillus licheniformis protein and application thereof to cardiovascular field |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103965303A true CN103965303A (en) | 2014-08-06 |
Family
ID=51235349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310034684.2A Pending CN103965303A (en) | 2013-01-30 | 2013-01-30 | Marine bacillus licheniformis protein and application thereof to cardiovascular field |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103965303A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008088493A2 (en) * | 2006-12-21 | 2008-07-24 | Danisco Us, Inc., Genencor Division | Compositions and uses for an alpha-amylase polypeptide of bacillus species 195 |
CN100463919C (en) * | 2006-11-15 | 2009-02-25 | 江苏省农业科学院 | Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method |
CN102102082A (en) * | 2010-12-16 | 2011-06-22 | 大连海洋大学 | Method for separating and purifying endogenous active strains in kelp |
-
2013
- 2013-01-30 CN CN201310034684.2A patent/CN103965303A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100463919C (en) * | 2006-11-15 | 2009-02-25 | 江苏省农业科学院 | Extracellular antiseptic protein for Bacillus subtilis and its separation and purification method |
WO2008088493A2 (en) * | 2006-12-21 | 2008-07-24 | Danisco Us, Inc., Genencor Division | Compositions and uses for an alpha-amylase polypeptide of bacillus species 195 |
CN102102082A (en) * | 2010-12-16 | 2011-06-22 | 大连海洋大学 | Method for separating and purifying endogenous active strains in kelp |
Non-Patent Citations (1)
Title |
---|
杨阳等: "地衣芽胞杆菌生物活性物质应用研究进展", 《生物技术进展》, vol. 3, no. 1, 25 January 2013 (2013-01-25), pages 22 - 26 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103330258B (en) | Cordyceps militaris health-care beverage prepared by liquid submerged fermentation and preparation method thereof | |
CN104940644A (en) | Method for fermenting dendrobium officinale employing lactic acid bacteria, as well as fermented product and application of dendrobium officinale | |
CN100484963C (en) | Exo-polysaccharide of lactobacillus casei and crude product, prepartion method and application | |
CN106916861B (en) | Method for simultaneously producing auricularia auricula polysaccharide and melanin | |
CN108244432A (en) | A kind of fermentation Cordyceps militaris probiotic beverage and preparation method thereof | |
CN108669501A (en) | A kind of fermentation pickled vegetable and preparation method thereof of low nitrite high dietary-fiber | |
CN107937311B (en) | Streptococcus thermophilus for high yield of gamma-aminobutyric acid, preservation and culture method and method for preparing fermented milk by using streptococcus thermophilus | |
CN113966832A (en) | Dendrobium nobile fermentation product and preparation method and application thereof | |
CN107853690A (en) | A kind of fermentation process of the beautiful ferment of promise | |
CN103478839A (en) | Glucan beverage and preparation method thereof | |
CN103229831A (en) | Preparation method of high-calcium goat yogurt fermented by lactobacillus plantarum containing ACE (Angiotensin Converting Enzyme) inhibitory peptides | |
CN106722942A (en) | The preparation method of moringa enzyme | |
CN106721770A (en) | Using the method for the red jujube prebiotic beverage of preparation ferment | |
CN111117894A (en) | Aspergillus oryzae strain and application thereof | |
CN110656151A (en) | Method for improving kidney-tonifying and yang-strengthening effects of sea cucumber | |
CN104277962B (en) | A kind of two-step fermentation prepares the method for Vinegar Beverage of Ganoderma Lucidum | |
CN102399840A (en) | Culture medium formulation for fermenting rainbow conk high-yield EPS and application thereof in cigarettes | |
CN102660439A (en) | Sea-buckthorn ice wine and making method thereof | |
CN111334440A (en) | Rhizopus oryzae CH5 and application thereof in extraction of ganoderma sinensis polysaccharide | |
CN107488616A (en) | Strain, probiotics facial mask, the preparation method of health preserving fungi bacterium tea and edible fungi tea | |
CN113186069A (en) | Lactobacillus strain microbial fermentation process | |
CN103222505A (en) | Preparation method of lactobacillus plantarum fermented goat milk containing ACE inhibitory peptide | |
CN112704230A (en) | Agar oligosaccharide powder product and application thereof | |
CN103965303A (en) | Marine bacillus licheniformis protein and application thereof to cardiovascular field | |
CN101168762B (en) | Method for preparing antihypertensive peptide from hairtail backbone by fermentation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140806 |